More than any other dosage form, injectable drugs require a manufacturing process that ensures sterility. Problems discovered at Genzyme's (Cambridge, MA) Allston Landing, Massachusetts, facility last fall illustrated how contamination can play havoc with a drugmaker's operations. But recent developments in disposable components and isolators are helping companies protect their products and the patients who depend on them.
Journal:
Pharmaceutical Technology, Mar 2, 2010
Copyright:
© Advanstar Communications, Inc. All rights reserved.
Full Article Link:
0 comments:
Post a Comment